Progress in understanding the mechanisms of resistance to BCL-2 inhibitors.
Journal Information
Full Title: Exp Hematol Oncol
Abbreviation: Exp Hematol Oncol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interest. Competing interests The authors declare that they have no competing interest."
Funding Disclosure
Evidence found in paper:
"Funding This work was supported by the Zhejiang Provincial Natural Science Foundation of China (LY20H080002), and the Medical Health Science and Technology Project of Zhejiang Provincial Health Commission (2019KY452)."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025